GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (OTCPK:TKPHF) » Definitions » Beginning Cash Position

TKPHF (Takeda Pharmaceutical Co) Beginning Cash Position : $5,585 Mil (As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Takeda Pharmaceutical Co Beginning Cash Position?

Takeda Pharmaceutical Co's Beginning Cash Position for the quarter that ended in Dec. 2024 was $5,585 Mil.

Takeda Pharmaceutical Co's quarterly Beginning Cash Position increased from Jun. 2024 ($2,900 Mil) to Sep. 2024 ($5,631 Mil) but then declined from Sep. 2024 ($5,631 Mil) to Dec. 2024 ($5,585 Mil).

Takeda Pharmaceutical Co's annual Beginning Cash Position declined from Mar. 2022 ($8,148 Mil) to Mar. 2023 ($6,357 Mil) and declined from Mar. 2023 ($6,357 Mil) to Mar. 2024 ($3,561 Mil).

Takeda Pharmaceutical Co Beginning Cash Position Historical Data

The historical data trend for Takeda Pharmaceutical Co's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Beginning Cash Position Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Beginning Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6,526.79 5,865.86 8,148.45 6,356.93 3,561.17

Takeda Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,208.98 1,924.72 2,900.04 5,631.27 5,584.75

Takeda Pharmaceutical Co Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Takeda Pharmaceutical Co Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (OTCPK:TKPHF) » Definitions » Beginning Cash Position
Comparable Companies
TSE:4507 TSE:4523 TSE:4540 TSE:4530 TSE:4506 TSE:4516 TSE:4887 TSE:4521 TSE:4547 TSE:4553 ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA ITCI
Traded in Other Exchanges
TAK:USA 4502:Japan 4502:Japan 4502:Japan 0A87:UK TKDA:Germany TKD:Germany TKD:Germany TKD:Germany TAKP34:Brazil TKD:Austria
Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Website
https://www.takeda.com
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.